Roche Touts MS Drug Ocrelizumab Results in Two Phase 3 Trials July 7, 2015 The drug significantly reduced the multiple sclerosis relapse rate over two years. Read More
ECA Medical Develops Orthopedic Single-Procedure Ratchet July 6, 2015 The product should reduce surgical costs by more than $1,000 per procedure, company claims. Read More
Compulsory Licensing Decided by Member States, European Commission Says July 6, 2015 The statement comes in response to concerns that the high price of hepatitis C drugs limits patient access. Read More
GlySure Introduces Intravascular Glucose Monitoring System July 2, 2015 The device is indicated for adult cardiac surgery patients in critical care. Read More
EMA Endorses Alexion’s Strensiq to Treat Rare Bone Disease July 2, 2015 The drug is indicated for the long-term treatment of hypophosphatasia. Read More
BioLight’s Bladder Cancer Test Secures CE Mark July 1, 2015 In a clinical trial, the product displayed sensitivity rates of 84.4 percent and specificity rates of 82.7 percent, company claims. Read More
UK Appeals Court Sides With Eli Lilly in Alimta Patent Case July 1, 2015 The court blocked Actavis from marketing a generic version of the drug until 2021. Read More
Centinel Spine’s Stalif Line Wins Expanded Indication June 30, 2015 The products can be used for multilevel, cervical spine fusion procedures. Read More
Guidance Goes After Overfilling of Vials, Ampules June 30, 2015 More than slight variations in amount of product should be justified. Read More
NCCN Recommends Opko’s 4Kscore for Prostate Cancer Early Detection June 29, 2015 The blood test is indicated for use prior to a first biopsy or after a negative biopsy. Read More
CBO Projects 21st Century Cures Act’s FDA Initiatives Cost $872M June 29, 2015 The measure was unanimously approved by the House Energy & Commerce Committee. Read More
Medtronic-Owned Covidien Settles Pelvic Mesh Cases June 26, 2015 The subsidiary agreed to settle an estimated 11,300 cases. Read More